AdaptHealth Corp. (AHCO)
NASDAQ: AHCO · IEX Real-Time Price · USD
10.64
-0.08 (-0.75%)
At close: Jul 19, 2024, 4:00 PM
10.69
+0.05 (0.47%)
Pre-market: Jul 20, 2024, 9:28 AM EDT

Company Description

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States.

The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.

It also offers wheelchairs, hospital beds, oxygen concentrators, CPAP masks and related supplies, wound care supplies, diabetes management supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies.

The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.

AdaptHealth Corp.
AdaptHealth logo
Country United States
Industry Medical Devices
Sector Healthcare
Employees 10,700
CEO Ms. Suzanne M. Foster

Contact Details

Address:
220 West Germantown Pike, Suite 250
Plymouth Meeting, Pennsylvania 19462
United States
Phone 610-630-6357
Website adapthealth.com

Stock Details

Ticker Symbol AHCO
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001725255
CUSIP Number 00653Q102
ISIN Number US00653Q1022
Employer ID 82-3677704
SIC Code 8082

Key Executives

Name Position
Richard Alan Barasch Chairman of the Board and Interim Chief Executive Officer
Joshua Parnes President and Director
Jason A. Clemens C.F.A. Chief Financial Officer
Albert A. Prast Chief Technology Officer
Christopher J. Joyce Secretary
Shaw A. Rietkerk Chief Operating Officer
Christie E. Archbold Chief Accounting Officer
Anton Hie Vice President of Investor Relations
Wendy Russalesi Chief Compliance Officer
Jonathan B. Bush General Counsel

Latest SEC Filings

Date Type Title
Jul 3, 2024 8-K Current Report
Jun 21, 2024 8-K Current Report
Jun 20, 2024 S-8 Securities to be offered to employees in employee benefit plans
Jun 11, 2024 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
May 16, 2024 S-8 Securities to be offered to employees in employee benefit plans
May 7, 2024 10-Q Quarterly Report
May 7, 2024 8-K Current Report
Apr 26, 2024 ARS Filing
Apr 26, 2024 DEF 14A Other definitive proxy statements
Apr 17, 2024 8-K Current Report